T1	Participants 303 345	assessed 27 subjects (12 men and 15 women)
T2	Participants 404 412	2 groups
T3	Participants 431 454	group (n = 15) received
T4	Participants 514 528	group (n = 12)
T5	Participants 643 651	Patient-
T6	Participants 757 765	Patient-
T7	Participants 895 906	Both groups
T8	Participants 980 993	Patient-Rated
T9	Participants 1079 1096	116 participants.
